Related Experiment Videos
Lipid abnormalities in the metabolic syndrome
1Carl T. Hayden VA Medical Center, Section of Metabolism, Endocrinology, & Nutrition, Department of Internal Medicine, 111 E, 650 East Indian School Road, Phoenix, AZ 85012, USA.
Current Diabetes Reports
|March 20, 2003
Summary
Metabolic syndrome, linked to insulin resistance, is increasingly prevalent and impacts major diseases. Early diagnosis and tailored management of associated dyslipidemias are crucial for preventing atherosclerotic events.
Area of Science:
- Endocrinology
- Cardiovascular Medicine
- Metabolic Disorders
Background:
- Metabolic syndrome is a cluster of metabolic and clinical issues stemming from insulin resistance.
- Its rising prevalence and significant impact on prevalent Western diseases necessitate routine clinical attention.
- Recent guidelines offer convenient and reliable diagnostic criteria for metabolic syndrome.
Purpose of the Study:
- To highlight the importance of routine diagnosis and management of metabolic syndrome.
- To emphasize the enhanced understanding of dyslipidemias and risk factors associated with metabolic syndrome.
- To advocate for comprehensive evaluation and aggressive, individualized treatment of associated risk factors for atheroprevention.
Main Methods:
- Review of recent guidelines for metabolic syndrome definition.
- Analysis of current understanding of dyslipidemias and atherosclerosis risk factors.
- Discussion of treatment strategies including statins and combination lipid therapy.
Main Results:
- New guidelines facilitate convenient and reliable diagnosis of metabolic syndrome.
- Improved understanding of complex dyslipidemias and associated risk factors.
- Aggressive, customized treatment of dyslipidemias and risk factors is feasible and desirable.
Conclusions:
- Routine diagnosis and management of metabolic syndrome are essential due to its prevalence and impact.
- Comprehensive evaluation and tailored treatment of associated dyslipidemias and risk factors are critical for preventing atherosclerotic events.
- While statins are effective, combination lipid therapy is often necessary for optimal atheroprevention.